Business Description
THC Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US60041A1025
Description
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -254.62 | |||||
| Debt-to-Equity | -0.22 | |||||
| Debt-to-EBITDA | -2.39 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 52.9 | |||||
| 3-Year EPS without NRI Growth Rate | 48.5 | |||||
| 3-Year FCF Growth Rate | 56.3 | |||||
| 3-Year Book Growth Rate | -6.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.8 | |||||
| 9-Day RSI | 9.96 | |||||
| 14-Day RSI | 17.17 | |||||
| 6-1 Month Momentum % | 1733.33 | |||||
| 12-1 Month Momentum % | 111.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.7 | |||||
| Shareholder Yield % | 31.74 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -618.21 | |||||
| ROIC % | -26.18 | |||||
| ROC (Joel Greenblatt) % | -30700 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| EV-to-EBIT | -2.75 | |||||
| EV-to-EBITDA | -2.76 | |||||
| EV-to-FCF | -8.35 | |||||
| Earnings Yield (Greenblatt) % | -36.36 | |||||
| FCF Yield % | -96.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:THCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
THC Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.008 | ||
| Beta | 279.35 | ||
| Volatility % | 3610.78 | ||
| 14-Day RSI | 17.17 | ||
| 14-Day ATR ($) | 0.000218 | ||
| 20-Day SMA ($) | 0.0052 | ||
| 12-1 Month Momentum % | 111.54 | ||
| 52-Week Range ($) | 0.0001 - 0.00785 | ||
| Shares Outstanding (Mil) | 34.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
THC Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
THC Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
THC Therapeutics Inc Frequently Asked Questions
What is THC Therapeutics Inc(THCT)'s stock price today?
The current price of THCT is $0.00. The 52 week high of THCT is $0.01 and 52 week low is $0.00.
When is next earnings date of THC Therapeutics Inc(THCT)?
The next earnings date of THC Therapeutics Inc(THCT) is 2024-06-14 Est..
Does THC Therapeutics Inc(THCT) pay dividends? If so, how much?
THC Therapeutics Inc(THCT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers